Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 1/14/14  and contains information from public web pages and contributions from the ZoomInfo community.

Dr. Mitchell H. Gold

Wrong Dr. Mitchell H. Gold?

Board Member

Dendreon Corporation
3005 First Avenue
Seattle, Washington 98121
United States

Company Description: Dendreon Corporation (Dendreon) is a biotechnology company focused on the discovery, development and commercialization of therapeutics that improve cancer treatment...   more
Background

Employment History

Board Memberships and Affiliations

Education

  • M.D.
    Rush Medical College
  • B.S.
    University of Wisconsin-Madison
  • MD
162 Total References
Web References
Jennerex Biotherapeutics
www.jennerex.com, 14 Jan 2014 [cached]
Mitchell H. Gold, MD
Dr. Mitchell H. Gold currently serves as executive chairman of Dendreon Corporation's Board of Directors. Previously, he served as president and chief executive officer of Dendreon since 2003, as well as vice president of business development and as chief business officer when he joined Dendreon in 2001. In April 2010 ? after more than 15 years of research and development, 15 clinical trials, and more than $1 billion raised ? Dendreon received approval from the FDA for the world's first autologous cellular immunotherapy, PROVENGE? (sipuleucel-T). Dr. Gold grew the company from having a market capitalization of $40 million to one of nearly $2 billion, establishing Dendreon as one of the largest biotech companies in the world. Prior to joining Dendreon, Dr. Gold previously served as vice president of business development and vice president of sales and marketing for Data Critical Corporation, a company engaged in wireless transmission of critical healthcare data, now a division of GE Medical. Dr. Gold was the president, chief executive officer, and a co-founder of Elixis Corporation, a medical information systems company. Dr. Gold currently serves on the board of the University of Washington/Fred Hutchinson Cancer Research Center Prostate Cancer Institute. Dr. Gold received his B.S. from the University of Wisconsin-Madison and his M.D. from Rush Medical College in Chicago. Dr. Gold was a resident physician in the Department of Urology at the University of Washington.
Dendreon Leadership Team - Dendreon.com
www.dendreon.com, 21 Feb 2013 [cached]
- Mitchell H. Gold, M.D.
WBBA - Washington Biotechnology & Biomedical Association
wbba.affiniscape.com, 12 Oct 2013 [cached]
Mitchell H. Gold, MD, CEO, Dendreon Corporation
Dr Mitchell H. ...
www.phacilitate.co.uk, 3 Jan 2014 [cached]
Dr Mitchell H. Gold
President & CEO Dendreon Corporation
HST Global
www.hstglobal.com, 30 Dec 2013 [cached]
Dr. Mitchell Gold, CEO and President of Dendreon stated "The FDA approval of Provenge is a testament to the courage of the patients and researchers who participated in our studies and is the culmination of nearly 15 years of research and development by our dedicated employees."
Other People with the name "Gold":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.
zirhbt201304